Nice post from Facebook Cytodyn page. CYTODYN VS 13D

New Post Public Reply Private Reply Replies (0) Message Board
bucweey34
762
Nice post from Facebook Cytodyn page.


CYTODYN VS 13D POINTS PART 3:

Last week the 13D group submitted their answers to claims to the court. The next day the judge issued an order of protection.

I have read the full 13 page order and it's basically just a court ordered NDA, with specific directions for how to handle documents containing sensitive info during discovery.

So it would appear the judge read the answers and determined it was prudent to move forward with discovery.

13D supporters will probably shout the judge saw something that convinced her 13D had a solid argument, I however see it different. In my opinion, the judge simply could not understand fully the answers by 13D and decided to err on the side of caution by moving forward.

To prove my hypothesis, let's break down two of the 13D answers. Why two? Because while being pages apart, they are interrelated questions and answers.

From Page 11

THE SIDLEY CLAIM:

...Dr. Patterson claims that 596,242 shares of (Cytodyn) are held beneficially by Incelldx...

The claim says Dr. Patterson in one place says he owns all those shares himself but in another place says it is Incelldx that owns the shares which means the shares are only partially owned by BP.

13D RESPONSE:

... Dr. Patterson is the beneficial owner of 596,242 shares of common stock of (Cytodyn). Dr. Patterson has requested that (Cytodyn) re-register these shares in the name of Incelldx. To Dr. Patterson knowledge this has not been done and the shares remain registered in Dr. Patterson name. Due to the above, Dr. Patterson disclaims beneficial ownership of 596,242 shares...

HUH? WHAT? Can someone "DISCLAIM" ownership of their shares? What the hell does this even mean? (Keep this answer in mind. We will come back to it)

On page 14, we get a related claim and response.

THE SIDLEY CLAIM.

C3) Mr. Beatty response to C1 fails to list the stock options that he indirectly owns through Incelldx's ownership of such options.

THE 13D RESPONSE:

The stock options are not owned by Incelldx. They are registered in the name of Dr. Patterson and he has agreed to register them in the name of Incelldx, when possible. Dr. Patterson has requested that (Cytodyn) release and re-register the shares but (Cytodyn) has not done so and claims they were never granted to Dr. Patterson and his inclusion in (Cytodyn) form S-3.... was erroneous despite not being amended or corrected...

OK, RAISE YOUR HAND IF YOU UNDERSTOOD ALL THAT?

Now let's analyze what they appear to be saying. We will start with the second claim and response.

The claim is simple and straightforward. Mr. Beatty owns a large portion of Incelldx. Incelldx owns 596,242 shares, therefore, Mr. Beatty indirectly owns Cytodyn through his ownership of Incelldx and failed to mention this in the filing.

The first sentence of the 13D answer appears to be a perfect response.

"The stock options are not owned by Incelldx!"

Hey, booyah, case closed. (KEEP THIS ANSWER IN MIND. WE ARE COMING BACK TO IT.) Except it's not. The 13D attorneys felt compelled to clarify the position.

"They are registered in the name of Dr. Patterson and he has agreed to register them in the name of Incelldx when possible."

Wait, what??? Let's analyze that. Notice the change in wording. Incelldx does not OWN shares but referring to Patterson, the shares are REGISTERED. Notice they don't claim the shares are OWNED by Patterson.

Because they aren't. After all the next thing they say is Patterson has agreed to register them in the name of Incelldx.

Why would he do that??? Duh, because they are owned by Incelldx.

The next sentence states Patterson has requested he re-register the shares but Cytodyn has refused (notice the positive/negative reinforcement -- BP is "trying" to do what is right while Cytodyn won't let him) because (Cytodyn) "...claims they were never owned by Patterson and his inclusion... was erroneous.

Okay, basically, there was a clerical error. A typo when filing an S-3. And Patterson was registered in error.

Patterson wants to re-register (basically correct the typo) but Cytodyn claims just because there is a typo, the ownership of the shares didn't change. Therefore, Patterson never owned them, and he can't do anything with shares he never owned.

Remember the answer to the first Sidley claim? BP said he DISCLAIMS ownership of the 596,242 shares. Well, of course, he never owned them, duh!

Which all leads to only one conclusion. Regardless of this typo involving Patterson, the shares were and always have been owned by Incelldx.

Finally, this brings us back to that very first sentence in the answer:

"The stock options are not owned by Incelldx"

BUUUZZZZZZ! INCORRECT!

Now you see why they had to clarify their statement.

Which finally brings us full circle to the Sidley claim. Mr. Beatty owns part of Incelldx which owns 596,242 shares of Cytodyn so Mr. Beatty indirectly owns Cytodyn shares.

Ding, ding, ding, the Sidley claim is correct!!!

Now do you think the judge did all this mental gymnastics? No, she just decided she can't make heads or tails of it and needs to hear direct testimony where she can sort it all out through questioning.

LAWYERS ARE UNDER OATH!!!

Whenever an attorney supplies paperwork to the court they attest that the information contained therein is correct and true to their best belief. An attorney risks their license if they purposefully lie in court documents.

Of course Belief leaves a crack in the door. An attorney could always claim something that turns out to be untrue by accident. But some things don't leave as large a crack.

Sidley has made a claim that Incelldx owns 596,242 shares of common stock in Cytodyn. They didn't pull that number from the Aether. You can wager your bottom dollar they saw the proof and firmly believe in it's veracity and are ready to prove it.

Meanwhile, the 13D answer basically lies, but then clarifies the position with the full truth. The 13D attorney certainly understood what they were writing. They were making very certain there erroneous claims didn't come back to bite them.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 7

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 3

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 2

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 6

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 4

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 1

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

ANI Pharmaceuticals Executive Stock Sale Sparks Investor Interest

Updated Category News Views 53

Stock Sale by ANI Pharmaceuticals Executive ANI Pharmaceuticals Inc. (NASDAQ: ANIP) has recently gained attention due to a notable stock transaction involving one of its high-ranking officials. Meredith Cook, who serves as the Senior Vice President, General Counsel, and Secretary at the company, sold 250 shares of common stock. This sale, which amounted to about $14,205,...

Continue Reading
Welcoming Dr. Morales: A New Era for NewHydrogen's Innovation

Updated Category News Views 174

Welcoming Dr. Austin Morales to NewHydrogen Dr. Morales brings expertise in dynamic reactor operation and advanced catalytic processes. NewHydrogen, Inc. (OTCQB: NEWH), a pioneer in clean hydrogen technologies, is thrilled to announce Dr. Austin Morales’ addition to its talented UCSB Technology Team. With his extensive background in catalytic processes and reactor...

Continue Reading
42com Expands its Telecom Services in Italy with New Offerings

Updated Category News Views 111

42com Launches New ISP and Satellite Infrastructure Services 42com has dramatically expanded its service portfolio with the acquisition of assets from Milano Teleport Srl. This move has enabled the company to introduce valuable new services, including 24/7 Network Operations Center (NOC) support for LEO, VSAT, 5G, and IoT technologies. Establishing a Strong Presence in...

Continue Reading
AI Professionals Face Major Gaps in Tools and Confidence

Updated Category News Views 85

Understanding the Current Landscape of AI Professionals A recent survey unveiled concerning insights into the AI landscape, revealing that a mere 34% of AI professionals feel fully prepared to tackle the challenges associated with their organizations' AI objectives. This stark finding indicates a growing tension between AI investments and actual readiness within companies...

Continue Reading
Brazil's Meal Vouchers Market Poised for Growth with AI Insights

Updated Category News Views 513

Brazil's Meal Vouchers Market Poised for Growth The market for meal vouchers and employee benefit solutions in Brazil is projected to experience remarkable growth, with estimates indicating an increase of USD 9.96 billion from 2025 to 2029. This growth is largely fueled by the advantages offered by tax benefits and AI-driven innovations. As organizations search for ways...

Continue Reading